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host cells, suggesting that mimicry of
different polymerization mechanisms
influences bacterial spread from cell to
cell and the outcome of infection.
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Burkholderia pseudomallei and B. mallei are bacte-
rial pathogens that cause melioidosis and glanders,
whereas their close relative B. thailandensis is non-
pathogenic. All use the trimeric autotransporter
BimA to facilitate actin-based motility, host cell
fusion, and dissemination. Here, we show that BimA
orthologs mimic different host actin-polymerizing
proteins. B. thailandensis BimA activates the host
Arp2/3 complex. In contrast, B. pseudomallei and
B. mallei BimA mimic host Ena/VASP actin polymer-
ases in their ability to nucleate, elongate, and bundle
filaments by associating with barbed ends, as well as
in their use of WH2 motifs and oligomerization for
activity. Mechanistic differences among BimA ortho-
logs resulted in distinct actin filament organization
andmotility parameters,which affected theefficiency
of cell fusion during infection. Our results identify
bacterial Ena/VASP mimics and reveal that patho-
gens imitate the full spectrum of host actin-polymer-
izing pathways, suggesting that mimicry of different
polymerization mechanisms influences key parame-
ters of infection.INTRODUCTION
The pseudomallei group of Burkholderia species are Gram-
negative bacteria that include the opportunistic human patho-
gens B. pseudomallei (Bp), which causes the severe disease
melioidosis, and B. mallei (Bm), a clonal descendant of Bp that
primarily infects equine but can cause acute human disease
(Cheng and Currie, 2005; Wilkinson, 1981). Bp and Bm are of
heightened concern because they are resistant to numerous an-
tibiotics, spread via an aerosol route, and exhibit low infectious
doses. A third species, B. thailandensis (Bt), is closely related
yet is not pathogenic to humans. All three share key virulence
factors despite their differences in infectivity. Because Bt infec-
tion in animals and cells recapitulates many features of Bp and
Bm virulence, it has been used as a model system to study
Burkholderia pathogenesis (Galyov et al., 2010; Haraga et al.,
2008; West et al., 2008). However, the basis for the dramatic
differences in Burkholderia virulence remains a mystery. Under-348 Cell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc.standing these differences will provide insight into the evolution
of virulence among closely related bacteria.
Key features of Burkholderia virulence include their ability to
invade host cells and escape from phagosomes into the cytosol,
where they replicate and undergo actin-based motility (Kespi-
chayawattana et al., 2000; Stevens et al., 2005a). As with other
pathogens, Burkholderia use actin-based motility to facilitate
cell-to-cell spread, which enables dissemination within hosts
while evading the immune system (Goldberg, 2001). However,
Burkholderia spread is distinct in that it can occur through
bacterial-mediated fusion of host cells (French et al., 2011; Kes-
pichayawattana et al., 2000) induced by type VI secretion
(Schwarz et al., 2014; Toesca et al., 2014), rather than the engulf-
ment of membrane protrusions. Regardless of the spreadmech-
anism, motility drives bacteria to the host plasma membrane to
facilitate spread.
To enable actin-based motility, pathogens express proteins
that mimic or activate host actin-nucleating factors to promote
the polymerization of actin monomers (G-actin) into filaments
(F-actin) that elongate at fast-growing barbed ends. Listeria
monocytogenes and Shigella flexneri produce mimics or activa-
tors of host nucleation-promoting factors (NPFs) to stimulate the
host Arp2/3 complex (Welch and Way, 2013), which constructs
branched actin filament networks (Campellone and Welch,
2010). Rickettsia species use an NPF that activates the Arp2/3
complex early in infection (Reed et al., 2014) and later use a
mimic of host formins (Haglund et al., 2010; Kleba et al., 2010;
Madasu et al., 2013), which nucleate filaments and processively
bind to barbed ends to enhance elongation rates (Paul and
Pollard, 2009). Vibrio and Chlamydia species, which do not
undergo motility, express proteins that use tandem actin mono-
mer-binding sequences to nucleate F-actin (Jewett et al., 2006;
Liverman et al., 2007; Namgoong et al., 2011; Pernier et al., 2013;
Tam et al., 2007; Yu et al., 2011). Despite this diversity, no path-
ogens have been shown to mimic host Ena/VASP proteins,
which are weak nucleators, bind barbed ends, enhance filament
elongation, and bundle filaments (Barzik et al., 2005; Breit-
sprecher et al., 2011; Hansen and Mullins, 2010; Krause et al.,
2003; Samarin et al., 2003; Winkelman et al., 2014). Within
this context, it is unclear whether Burkholderia mimics or acti-
vates host nucleators or nucleates actin by an unknown mecha-
nism. Additionally, the consequences of different nucleation
mechanisms on actin-based motility and infection have not
been examined.
Burkholderia actin-based motility requires the Burkholderia
intracellular motility A (BimA) protein (Schell et al., 2007; Sitthidet
et al., 2010; Stevens et al., 2005b), a member of the trimeric au-
totransporter (AT) family. Trimeric ATs contain highly conserved
C-terminal sequences that mediate secretion, localization to the
outer membrane, and trimerization (Cotter et al., 2005; Dautin
andBernstein, 2007). These include a b barrel, as well as an adja-
cent 35 residue a helix (Stevens et al., 2005b), which in other
trimeric ATs forms a trimeric coiled coil that is positioned
inside the barrel (Meng et al., 2006). Trimeric ATs also contain
N-terminal passenger domains that are exposed on the bacterial
surface. Sequence comparisons suggest that the passenger do-
mains of BimA from Bt, Bp, and Bm polymerize host actin by
different mechanisms (Stevens et al., 2005b). BtBimA contains
putative actin-binding WASP homology 2 (WH2) and Arp2/3-
binding central and acidic (CA) motifs that are conserved among
NPFs that activate the Arp2/3 complex (Campellone and Welch,
2010). Previous work showed that the BtBimA CA motifs are
required to activate Arp2/3 nucleation in vitro and promote actin
association in host cells (Sitthidet et al., 2010). In contrast,
BpBimA and BmBimA contain three (Bp) or one (Bm) putative
WH2 motifs and lack CA sequences. Although two of the three
putative BpBimA WH2 sequences were shown to be required
for actin binding, nucleation, and plaque formation (Sitthidet
et al., 2011), the activity of BmBimA has not been examined. It
also remains unclear what molecular mechanisms BpBimA and
BmBimA use to nucleate actin and the role trimerization plays
in this process.
Here, we investigated the mechanisms of actin assembly and
motility driven by BimA orthologs from different Burkholderia
species. Despite the conservation of key virulence factors
(French et al., 2011; Galyov et al., 2010; Haraga et al., 2008),
we found that Bt, Bp, and Bm have evolved divergent mecha-
nisms for actin polymerization. These differences result in
Burkholderia that generate actin tails with distinct filament archi-
tectures and exhibit different efficiencies of motility and host-cell
fusion, providing one potential explanation for the increased viru-
lence of Bp and Bm relative to Bt. These observations demon-
strate that intracellular pathogens employ the full spectrum of
actin assembly pathways and suggest that distinct mechanisms
allow microbes to fine-tune motility to control spread during
infection.
RESULTS
BtBimA Activates the Host Arp2/3 Complex to Nucleate
Branched Filaments, whereas BpBimA and BmBimA
Independently Nucleate Unbranched Filaments
Previous studies indicated that BtBimA requires its CA motifs
and the host Arp2/3 complex for actin nucleation, whereas
BpBimA nucleates actin independent of Arp2/3 (Sitthidet et al.,
2010; Stevens et al., 2005b). The activity of BmBimA was not
investigated. In these studies, incomplete BtBimA and BpBimA
passenger domains that lacked trimeric coiled coils were fused
to GST, which would induce non-native dimerization (Sitthidet
et al., 2010, 2011; Stevens et al., 2005b). The activity of these
constructs was modest (1.5- to 2.5-fold increased polymeriza-
tion rates). We hypothesized that the full passenger domains
in their native oligomeric states would exhibit higher nucleation
activities that would be dependent (BtBimA) or independent(BpBimA, BmBimA) of Arp2/3 complex. To test this, we purified
versions of each ortholog that spanned the passenger domain
and extended through the trimeric coiled coil (Figure 1A) (Meng
et al., 2006; Szczesny and Lupas, 2008). We used pyrene
actin-polymerization assays to test each purified BimA for activ-
ity. BtBimA alone had little nucleation activity (Figures S1A and
S1B), yet it activated the Arp2/3 complex in a concentration-
dependent manner (>5-fold increase relative to actin alone),
indicating that it functions as an NPF (Figures 1B and 1C). In
contrast, BpBimA and BmBimA displayed robust nucleation ac-
tivity (>7- or 8-fold increase relative to actin alone), and Arp2/3
addition had no effect (Figure S1B). To compare their potencies,
we determined the time it took to reach half-maximum fluores-
cence over a range of BimA concentrations and fit the resulting
curves (Figure 1C). All three orthologs are potent nucleators
with 230 nM BtBimA (with 50 nM Arp2/3), 60 nM BpBimA, and
5 nM BmBimA required for half-maximum activity. Consistent
with its ability to activate the Arp2/3 complex, BtBimA and
Arp2/3 generated branched actin filaments (Figure 1D). In con-
trast, BpBimA and BmBimA generated unbranched filaments.
Thus, BtBimA is an NPF that activates Arp2/3, whereas BpBimA
and BmBimA independently nucleate actin, similar to host pro-
teins in the formin, tandem monomer nucleator, and Ena/VASP
families.
BpBimA and BmBimA Bind Filament Barbed Ends,
Processively Elongate Filaments, and Remove Capping
Protein from Filaments
Formins and Ena/VASP proteins processively track barbed ends
and alter their elongation rates (Paul and Pollard, 2009), whereas
tandem monomer nucleators have not been shown to track
growing filament ends (Carlier et al., 2011; Namgoong et al.,
2011; Pernier et al., 2013). To compare BimA behavior to that
of members of these families, we investigated how BimA ortho-
logs interact with filament ends and tested whether they affect
elongation. We labeled BpBimA and BmBimA with Alexa Fluor
488 at Cys residues that were introduced at their C termini and
used total internal reflection fluorescence (TIRF) microscopy to
monitor the effect of BimA on rhodamine-labeled actin polymer-
ization. BmBimA and BpBimA bound and remained associated
with barbed ends as they grew (Figure 2A; Movies S1 and S2).
Growth rate measurements of barbed ends in the presence or
absence of BimA indicated that BmBimA and BpBimA increased
elongation rates by 3.5- to 4.5-fold relative to actin alone. To
measure their apparent affinities for barbed ends, we monitored
elongation of pre-polymerized actin seeds with increasing BimA
concentrations and fit the concentration dependence of the
decrease in time to half-maximum fluorescence (Figure 2B).
These measurements produced apparent affinities for barbed
ends of 350 nM for BpBimA and 3 nM for BmBimA, similar to
the barbed-end affinities of formin and Ena/VASP proteins (Han-
sen and Mullins, 2010; Harris et al., 2004; Otomo et al., 2005;
Pruyne et al., 2002; Winkelman et al., 2014).
Ena/VASP proteins are further distinguished from formins by
the ability of at least one familymember (Ena) to bundle and elon-
gate two filaments at once (Winkelman et al., 2014). BmBimA
and BpBimA also frequently gathered two or even three fila-
ments and mediated their simultaneous elongation (Figures 2CCell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc. 349
Figure 1. BtBimA Mimics Host NPFs, whereas BpBimA and BmBimA Independently Nucleate Actin
(A) Domain schematics of BimA from different Burkholderia species. Actin-related and oligomerization sequences are shown. Numbers refer to amino acid
position in full-length proteins. W, WASP homology 2; C, central; A, acidic; P, proline rich; Coil, trimeric coiled coil.
(B) Pyrene actin polymerization reactions with increasing BimA concentrations with Arp2/3 complex (Bt) or in its absence (Bp, Bm).
(C) The time to half-maximum fluorescence of the polymerization curves in (B) normalized to actin alone. The means ± SD are shown, and fits of each data set are
reported to estimate the concentration at which half-maximum activity is observed.
(D) Epifluorescence images of polymerization reactions containing BtBimA with Arp2/3 complex, BpBimA, or BmBimA after 15 min that were stabilized and
stained with rhodamine phalloidin.
Scale bars, 5 mm. See also Figure S1.and S2; Movies S3, S4, S5, and S6). Bundled filaments bound by
a single BimA spot grew at similar rates relative to each other
(Figure 2D) and to individual BimA-elongated filaments (Fig-
ure 2E). Thus, in this regard, BpBimA and BmBimA activity
closely resembles that of Ena/VASP proteins.
In cells, barbed ends are often capped by CapZ, which pre-
vents filament elongation (Cooper and Sept, 2008). Purified
CapZ displays a high affinity of2 nM for barbed ends (Caldwell
et al., 1989) and a slow dissociation rate from barbed ends
(30 min half-life) (Schafer et al., 1996). Formins and Ena/
VASP proteins compete with CapZ to prevent capping (Barzik
et al., 2005; Breitsprecher et al., 2008; Paul and Pollard, 2009)
but have not been reported to remove CapZ from pre-capped
filaments. To test whether BpBimA and BmBimA have anti-
capping activity, we monitored their ability to promote filament
elongation when added to pre-formed actin seeds simulta-
neously with CapZ (data not shown) or when added 5 min after
filaments had been pre-capped with CapZ (Figure 2F). Under350 Cell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc.both conditions, 10 nM CapZ alone completely inhibited elonga-
tion, whereas the addition of 30 nM BpBimA or BmBimA to
pre-capped filaments allowed filament elongation. These results
suggest that BpBimA and BmBimA have the unusual ability to
remove CapZ from barbed ends to enable elongation. Together,
our results demonstrate that BpBimA and BmBimA are barbed-
end-binding proteins that increase elongation rates, bundle fila-
ments, and have anti-capping activity, similar to host Ena/VASP
actin polymerases.
Oligomerization Is Required for BpBimA and BmBimA
Activity
One feature of Ena/VASP proteins required for their actin poly-
merase activity is a tetrameric coiled coil located at the C termi-
nus (Breitsprecher et al., 2008; Hansen and Mullins, 2010; Ku¨h-
nel et al., 2004). Based on the functional similarities of BpBimA
and BmBimA with Ena/VASP proteins, we predicted that trimeri-
zation is important for BimA barbed-end-binding and elongation
Figure 2. BmBimA and BpBimA Processively Bind Growing Filament Barbed Ends, Increase Elongation Rates, Bundle Filaments, and
Outcompete CapZ for Barbed-End Binding
(A) Left, TIRF images showing BmBimA-AF488 and BpBimA-AF488 (green) and rhodamine-labeled actin (magenta). Time (s) is indicated. Scale bars, 3 mm. Right,
filament length (number of subunits 3 1,000) over time for a minimum of 10 filaments with the mean elongation rate (sub/s ± SEM) listed.
(B) Left and middle, pyrene elongation assays with a range of BimA concentrations. Right, the time to half-maximum fluorescence normalized to actin alone for
BmBimA (green) or BpBimA (purple) with the mean apparent KD ± SD listed.
(legend continued on next page)
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Figure 3. BpBimA and BmBimA Oligomeri-
zation Is Required for Actin Nucleation and
Barbed-End Binding
(A) Alignment of the trimeric coiled coils from
BpBimA and BmBimA with the Hia trimeric coiled
coil (Meng et al., 2006). Positions replaced with
Asp residues in the BimA8D mutants are outlined
in black. Hydrophobic residues are blue, and
charged residues orange.
(B) Domain schematics of wild-type and BimA8D
mutants in which eight positions were changed to
Asp residues are shown above gel-filtration elution
profiles of wild-type and mutant proteins.
(C) The time to half-maximum fluorescence
normalized to actin alone in polymerization re-
actions with increasing BimA8D proteins. The
means ± SD are shown with the wild-type data
from Figure 1C for reference.
(D) Elongation reactions with 10 nMCapZ andwith
or without BimA8D proteins.activities. To estimate the oligomeric state of wild-type and
mutant BimA proteins, we determined the behavior of wild-
type BimA on a gel-filtration column. BpBimA and BmBimA
eluted at volumes corresponding to globular proteins of much
larger molecular weight (>500 kDa) than expected based on their
sequences (127 kDa for BpBimA; 88 kDa forBmBimA; Figure 3B).
However, other trimeric ATs display aberrant behavior that is
attributed to their elongated structures (Cotter et al., 2005; Hart-
mann et al., 2012; Mack et al., 1994). Next, we replaced eight
residues of the predicted a helix with aspartic acid (D) to disrupt
the formation of the trimeric coiled coil (Figure 3A). The resulting
BpBimA8D and BmBimA8D mutants eluted at smaller sizes(C) TIRF images of BmBimA-AF488 (arrowhead) elongating two (top) or three (bottom) filaments (colors as in
(D) Graph of filament length (number of subs 3 1,000) over time for pairs of co-elongating filaments (each p
(E) Mean elongation rates (sub/s ± SEM) for actin alone or for single filaments or two- and three-filament bun
BpBimA-AF488 (right, purple). Asterisks denote paired samples that are significantly different (one-way ANO
(F) Left and middle, elongation reactions first incubated with 10 nMCapZ, followed by BimA and G-actin addit
normalized to actin alone (dashed black line) for BmBimA (green) or BpBimA (purple) are shown with the me
See also Figure S2 and Movies S1, S2, S3, S4, S5, and S6.
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by gel filtration (Figure 3B), suggesting
that the higher oligomeric state of the
wild-type proteins was disrupted and
that the trimeric coiled coil mediates
oligomerization.
To determine the importance of
oligomerization in actin nucleation and
elongation, we compared the activity of
each BimA8D mutant with wild-type
BimA in pyrene actin assembly assays.
Both BpBimA8D and BmBimA8D lacked
detectable nucleation activity, and at
high concentrations, both mutants in-
hibited polymerization, suggesting that
they sequester G-actin (Figure 3C).
Neither mutant could relieve CapZ inhibi-tion of elongation at concentrations two orders of magnitude
higher than that at which wild-type BimA relieved inhibition
(Figure 3D). Thus, oligomerization of BpBimA and BmBimA is
required for actin nucleation, barbed-end elongation, and anti-
capping activity, similar to the requirement of tetramerization
for Ena/VASP actin polymerase activity.
WH2 Motifs Are Required for BpBimA and BmBimA
Activity
Ena/VASP barbed-end binding and filament elongation require
two WH2 sequences (also called the globular actin-binding or
GAB and filamentous actin-binding or FAB motifs) (BachmannA).
air is in matched colors of solid and dashed lines).
dles elongated with BmBimA-AF488 (left, green) or
VA; p < 0.0001).
ion. Right, the times to half-maximum fluorescence
ans ± SD.
Figure 4. WH2 Requirements for BpBimA and BmBimA G-Actin Binding and Nucleation
(A) Alignment of predicted WH2 sequences from BimA orthologs with known WH2 (GAB and FAB) sequences from human VASP and Drosophila Ena. The
conserved a helix and LKKT motif are indicated. Hydrophobic residues are blue, and charged residues orange. Boxed residues were mutated to AA.
(B) Domain schematics of WH2 mutant BimA proteins. Predicted WH2 motifs that were mutated are outlined in blue and denoted by AA.
(C) Anisotropy measurements of monomeric actin488 binding to BimA. Data are represented by circles, and Hill equation fits are shown as solid lines. The means
KD ± SD from at least two experiments are listed.
(D) The time to half-maximum fluorescence normalized to actin alone in polymerization reactions with BimA. The means ± SD are shown with wild-type data from
Figure 1C for reference.et al., 1999; Hansen and Mullins, 2010). BpBimA and BmBimA
contain three (Bp) or one (Bm) putative WH2 sequences (Fig-
ure 1A) (Stevens et al., 2005a, 2005b) that are implicated in actin
binding, and we hypothesized that each BimA would use these
sequences for nucleation and elongation, similar to Ena/VASP
proteins. We determined whether the BimA WH2 sequences
are competent for actin binding by replacing two positions of
the conserved LKKT signature sequence with alanines (Figures
4A and 4B). To measure G-actin binding, we titrated increasing
wild-type or WH2 mutant BimA into a fixed concentration of
Alexa Fluor 488-labeled G-actin (actin488) in low ionic strength
buffer to prevent actin polymerization (Figure 4C). Anisotropy
measurements with increasing BimA produced saturable bind-
ing curves that were fit using the Hill equation.Wild-type BpBimA
and BmBimA bound actin488 with apparent affinities of 350 nM
and 670 nM (Figure 4C). Mutating any single predicted WH2
sequence in BpBimA (BpW1, BpW2, and BpW3 mutants) ormutating the first two WH2 motifs together (BpW1W2) had little
effect on G-actin binding (Figure 4C). However, simultaneously
mutating all three WH2 sequences in the BpW1W2W3 mutant
severely reduced binding (KD 13 mM). The single BmW mutant
also exhibited a significant reduction in affinity relative to wild-
type BmBimA (KD 17 mM). These data demonstrate that
BmBimA contains one WH2 motif capable of binding G-actin
and suggest that BpBimA contains up to three WH2 motifs that
bind G-actin.
To determine whether BimA WH2 motifs are required for fila-
ment nucleation and elongation, we used the pyrene actin as-
sembly assay to test each WH2 mutant for its ability to nucleate
actin. Although the BpW1 and BpW2 mutants bound G-actin
with high affinity, they lacked nucleation activity, as evidenced
by the absence of a decrease in time to half-maximum fluores-
cence intensity (Figure 4D). Notably, these mutants inhibited
polymerization at concentrations above 1 mM, which is likelyCell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc. 353
Figure 5. BimA from Different Burkholderia Species Mediates the Formation of Distinct Actin Tails and Parameters of Actin-Based Motility
(A) Merged images showing Cos7 cells infected with different Bt strains that constitutively express RFP (magenta). F-actin was stained with Alexa Fluor 488
phalloidin (green). Scale bars, 5 mm.
(B) Mean actin-tail lengths for the indicated strains in Cos7 and A549 cells. Boxes outline the 25th and 75th percentiles, midlines denote themedians, and whiskers
show minimum and maximum lengths. Asterisks denote lengths significantly different from BtBimA in that cell type (one-way ANOVA; p < 0.05).
(C) Percent bacteria with actin tails (±SD).
(D) Percent bacteria with actin tails (±SD) without or with 1 hr treatment with DMSO, the Arp2/3 inhibitor CK-666, or the inactive compound CK-689. nd, no
difference.
(legend continued on next page)
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due to remaining intact WH2 motifs sequestering G-actin. In
contrast, the activity of BpW3 was similar to that of wild-type
BpBimA, indicating that the third WH2 motif is not required for
activity. BpW1W2 and BpW1W2W3 were unable to nucleate
actin, and BpW1W2W3 also lacked inhibitory activity, consistent
with the low affinity of this mutant for G-actin (Figure 4C). Thus,
although all three BpBimA WH2 motifs may bind actin mono-
mers, only the N-terminal twoWH2motifs are required for nucle-
ation activity. For BmBimA, the sole WH2 mutant BmW lacked
detectable nucleation activity and did not inhibit actin polymeri-
zation, indicating that this WH2 motif is required for nucleation
(Figure 4D). Together with the requirement for oligomerization,
these results suggest that BpBimA uses up to six and BmBimA
uses up to three WH2 motifs within a BimA trimer to mediate
actin nucleation and elongation. Thus, like Ena/VASP proteins,
BpBimA and BmBimA require oligomerization and WH2 motifs
for their actin polymerase activities.
Mechanistic Differences among BimA Orthologs
Expressed in Bt Result in Distinct Filament Organization
and Parameters of Actin-Based Motility
To compare how differences in the biochemical properties of
BimA orthologs affect actin filament organization and actin-
based motility by Burkholderia, we replaced the endogenous
copy of Bt bimA with an identical copy of Bt bimA or with bimA
from Bp or Bm. To assess BimA synthesis and localization, we
engineered strains producing internally FLAG-tagged versions
of BimA. Bacteria producing FLAG-BimA were compared with
those expressing the corresponding untagged BimA orthologs
in plaque assays and formed identical numbers and sizes of pla-
ques as the untagged versions (data not shown). We found that
FLAG-BtBimA and FLAG-BmBimA were produced at similar
levels, whereas FLAG-BpBimA was produced at 2- to 2.5-fold
higher levels than the others (Figure S3A). All displayed polar
localization similar to endogenous BimA in Bp (Figure S3B)
(Sitthidet et al., 2011; Stevens et al., 2005b) and also enabled
actin-tail formation byBt following infection of tissue culture cells
(Figure 5A), similar to previous results for BimA orthologs in Bp
(Stevens et al., 2005a). Unless otherwise noted, data were
obtained using strains expressing untagged BimA.
Confocal microscopy of actin-tail structures generated by
each strain indicated that tails produced by BtBimA were curved
and consisted of a dense actin network (Figure 5A; FLAG-BimA
images are shown). In contrast, BpBimA and BmBimA produced
longer, straighter tails that consisted of bundled F-actin strands
(Figure 5B). Interestingly, the proportion of BpBimA bacteria
associated with tails was moderately reduced and that of
BmBimA bacteria was severely reduced relative to BtBimA bac-
teria (Figure 5C), suggesting differences in motility initiation. The
Arp2/3 complex localized specifically to BtBimA tails, but not
BpBimA or BmBimA tails, as monitored by immunofluorescence(E) Mean actin, Arp2/3, or non-specific 488 nm fluorescence intensities (3 1,000
(F) Tracks (ten per strain) depicting motility over 100 s for bacteria in Cos7 cells.
(G) Motility efficiency from at least 80 tracks per strain, calculated as described
(H) Motility velocity over 40 s for each strain in Cos7-Lifeact-EGFP cells untreate
For all panels except (B), asterisks denote paired samples that are statistically dif
Movie S7.staining and by the presence of Arp3-GFP (Figures 5E and S3D–
S3F). Furthermore, treatment of infected cells with the Arp2/3
complex inhibitor CK-666 (but not the control compound CK-
689) reduced the frequency of tail formation by BtBimA, whereas
tails formed by BpBimA or BmBimAwere unaffected (Figure 5D).
Thus, BtBimA requires Arp2/3 complex activity to produce
shorter and curved actin tails, whereas the Ena/VASP mimics
BpBimA and BmBimA work independent of Arp2/3 to produce
longer tails with bundled filaments.
We next used time-lapse imaging to compare actin-based
motility parameters among strains producing different BimA or-
thologs. Oncemovement was initiated, all three strains exhibited
similar average velocities of 30 mm/min, with rates varying
widely for each strain (Figure S3C). However, the movement
paths of the BtBimA strain were more curved, whereas those
of BpBimA and BmBimA bacteria were straighter (Figure 5F;
Movie S7). To quantify path straightness and motility efficiency,
we divided the linear displacement by the total distance traveled
over 40 s for each bacterium. By this criteria, the BpBimA and
BmBimA strains moved more efficiently than the BtBimA strain
(Figure 5G). We also monitored motility following treatment
with increasing concentrations of cytochalasin D (CD), a drug
that binds to and inhibits growth of barbed ends. Although treat-
ment with 250 or 500 nMCD reduced the frequency ofmotility for
all strains, it completely blockedmovement by the BtBimA strain,
whereas some BpBimA and BmBimA bacteria resisted treat-
ment and moved at rates similar to those in untreated cells (Fig-
ure 5H). This is consistent with the ability of these proteins to
relieve CapZ inhibition. Overall, these results demonstrate that
Arp2/3-dependent and Ena/VASP-like mechanisms of actin
nucleation and elongation can drive similar rates of actin-based
motility. However, distinct motility mechanisms also result in dif-
ferences in motility initiation, paths, efficiency, and susceptibility
to inhibition by actin-disrupting drugs.
The Mechanism of BimA Actin Assembly Impacts the
Efficiency of Host Cell Fusion
Bacterial-mediated host cell fusion is essential for Burkholderia
virulence, and fusion depends on actin-based motility (French
et al., 2011; Schwarz et al., 2014). We therefore hypothesized
that differences in actin polymerization mechanisms and motility
impact Burkholderia-mediated fusion. To compare fusion effi-
ciencies, strains producing different BimA orthologs were as-
sessed for their ability to form plaques on host cell monolayers.
BtBimA and BpBimA strains formed similarly sized plaques, but
the BmBimA strain produced smaller plaques in both Cos7 and
A549 cells (Figure 6A). This plaque defect did not correlate with a
reduction in BmBimA expression, a defect in localization (Figures
S3A and S3B), intracellular replication (data not shown), slower
rate of motility (Figure 5D), or differences in movement paths
(Figure 5F). Instead, the reduced plaque size strongly correlated) from at least 10 actin tails (±SEM) are plotted along the first 12.5 mm of tail.
in the text.
d or treated with DMSO or CD. Mean frequencies of motile bacteria are listed.
ferent from one another (one-way ANOVA; p < 0.0001). See also Figure S3 and
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Figure 6. BimA Mechanisms of Actin Nucleation Impact Actin Tail Formation and Host Cell Fusion
(A) Plaque diameters in Cos7 or A549 cell monolayers infected with Bt expressing wild-type BtBimA, BpBimA, or BmBimA.
(B) Merged images of Cos7 cells infectedwith wild-type ormutant BimA-expressingBt strains that constitutively express RFP (magenta). F-actin was stainedwith
Alexa Fluor 488 phalloidin (green). Scale bars, 5 mm.
(C) Plaque diameters in Cos7 or A549 cell monolayers infected with Bt expressing wild-type or mutant BimA.
(A and C) Boxes outline the 25th and 75th percentiles, midlines denote the medians, and whiskers show minimum and maximum tail lengths. Asterisks denote
significantly different sample pairs (one-way ANOVA; p < 0.05). See also Figure S4.with a low frequency of actin-tail association (<5%; Figure 5C),
suggesting that the initiation of actin-based motility is a crucial
parameter for Burkholderia host cell fusion.
We investigated the mechanisms used by BpBimA and
BmBimA to enable intracellular motility and fusion by testing
the prediction that each BimA would require one or more WH2
motifs to drive movement during infection. We generated Bt
strains in which we replaced endogenous bimA with genes en-
coding WH2 mutants (including BpW1, BpW2, BpW3, and
BmW). The synthesis and localization of BimA in each strain
were similar to those of wild-type BimA as determined by immu-
nofluorescence staining against internal FLAG tags (Figure S4).
Consistent with their lack of polymerization activity, the BpW1
and BpW2 mutants had no detectable association with F-actin,
whereas the BpW3 mutant generated actin tails similar to wild-
type BpBimA (Figure 6B). The BmW mutant similarly lacked
actin association. We next examined the efficiency of fusion
by measuring the plaque-forming ability of the mutants. The
BpW1, BpW2, and BmW strains were completely defective in356 Cell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc.plaque formation, whereas the BpW3 strain generated a similar
number and size of plaques as the wild-type BpBimA strain (Fig-
ure 6C). Thus, BpBimA requires WH2 motifs W1 and W2, and
BmBimA requires its sole WH2 motif for actin-based motility
and fusion during Bt infection. These results demonstrate that
molecular mimicry of host Ena/VASP proteins is crucial for
actin-based motility driven by BpBimA and BmBimA in host
cells.
DISCUSSION
Microbe-driven actin-basedmotility plays a crucial role in spread
and virulence of many pathogens and is also used as a model
system to understand actin dynamics in host cells. Almost all
motile pathogens use an actin-polymerization mechanism that
depends on the host Arp2/3 complex (Truong et al., 2014; Welch
and Way, 2013), with the exception of Rickettsia species that
also use a formin-like mechanism late in infection (Haglund
et al., 2010; Madasu et al., 2013; Reed et al., 2014). Here we
Figure 7. AModel for BtBimA, BpBimA, andBmBimANucleation and
Formation of Actin Tails and Multinucleated Giant Cells
(A) BtBimA activates host Arp2/3 complex using its WCA domain to nucleate
branched actin networks. BpBimA nucleates and elongates filaments from
barbed ends using its two N-terminal WH2 motifs, whereas BmBimA exhibits
the same activities using its single WH2 motif to generate bundled filaments.
(B) BtBimA and Arp2/3 form shorter tails with branched actin networks.
BpBimA and BmBimA produce longer tails of bundled filaments.
(C) Burkholderia synthesizing BtBimA or BpBimA form more actin tails and
generate larger multinucleated giant cells compared with bacteria producing
BmBimA.show that virulent Burkholderia species employ a previously un-
described mechanism to co-opt actin for motility, mimicking
Ena/VASP actin polymerases to nucleate, elongate, and bundle
filaments.
In contrast to BtBimA activation of the Arp2/3 complex, we
found that BpBimA and BmBimA function independently of
Arp2/3. Both directly nucleate actin, bind processively to fila-
ment barbed ends, and increase the elongation rate of bundledfilaments (Figure 7). Moreover, they have the unusual ability to
dissociate CapZ from barbed ends, a property they share with
the Vibrio cholerae VopF protein (Pernier et al., 2013), as well
as to resist the action of the drug CD during infection. These ac-
tivities most closely mirror those of the Ena/VASP family of actin
polymerases (Krause et al., 2003), which similarly bind to fila-
ment barbed ends, processively elongate filaments, and under
some conditions protect growing barbed ends from CapZ inhibi-
tion (Barzik et al., 2005; Bear et al., 2002; Breitsprecher et al.,
2008; Hansen and Mullins, 2010; Schirenbeck et al., 2006; Win-
kelman et al., 2014). Perhaps the most striking parallel between
the activities of these proteins is their shared ability to gather and
elongate multiple filaments simultaneously, which is a recently
described property of Drosophila Ena (Winkelman et al., 2014).
This enables BpBimA and BmBimA to generate networks of
bundled filaments similar to those formed by Ena/VASP proteins
in mammalian cells (Krause et al., 2003).
BpBimA and BmBimA also display sequence requirements
similar to those of Ena/VASP for their activity, including both
WH2 and coiled coils. BimA trimerization would result in the
close positioning of multiple WH2 sequences (three for BmBimA
and up to nine for BpBimA), which may promote elongation
through the proximity of G-actin and barbed-end-binding sites
(Figure 7). Higher-order oligomerization of BpBimA or BmBimA
may also contribute to their ability to bundle and elongate multi-
ple filaments, similar to the tetramerization requirement and role
of clustering in Ena/VASP protein processivity (Bachmann et al.,
1999; Breitsprecher et al., 2008; Hansen and Mullins, 2010; Sa-
marin et al., 2003).
Our analysis also revealed thatBt producing different BimA or-
thologs generate actin tails with distinct organization (Figure 7)
and move differently within host cells. BtBimA bacteria generate
shorter and curvier tails that are densely packed with actin.
Although they move at velocities similar to bacteria expressing
other orthologs, they exhibited lower motility efficiency due to
their curvier paths. These characteristics are similar to those of
L. monocytogenes, which use the NPF ActA to activate Arp2/3
and polymerize actin (Welch et al., 1998). In contrast, Bt synthe-
sizing BpBimA or BmBimA produce longer, straighter tails
consisting of bundled filaments and exhibit a higher motility effi-
ciency due to straighter paths. The bundled filament organiza-
tion in these tails is consistent with the Ena/VASP-like activities
of BpBimA and BmBimA in vitro. Thus, virulentBurkholderia spe-
cies have evolved a distinct molecular mechanism for efficient
actin-based motility.
Actin-based motility driven by BimA orthologs also differs in
promoting host cell fusion. In particular, the BmBimA strain ex-
hibited reduced fusion efficiency relative to the BtBimA and
BpBimA strains. Reduced fusion did not correlate with altered
velocity, directionality of movement, or even the underlying poly-
merization mechanism. Fusion did, however, correlate with a
5- to 10-fold reduction in the frequency of BmBimA-driven
tail formation and motility initiation. This defect is surprising
considering that BmBimA possesses more potent nucleation
and elongation activity than BpBimA in vitro. Thus, despite its
increased activity in isolation, BmBimA appears to be a less effi-
cient actin nucleator in cells. Differences between the activity of
BimA outside versus inside cells may be due to differentialCell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc. 357
requirements for other bacterial or host factors that play impor-
tant roles in motility. For example, BmBimA may require addi-
tional host actin regulators that are present in equine cells but
absent from human cells. Regardless, these findings suggest
that the ability of BimA to initiate actin-based motility is a partic-
ularly crucial parameter to enable host cell fusion.
Why has BimA evolved distinct mechanisms of generating
actin filaments?Bp is a soil saprophyte that infects a broad range
of mammals (Galyov et al., 2010), and Bm is a clonal descendent
ofBp that hasundergone reductive genomeevolution andcannot
survive outside of a host (Galyov et al., 2010; Godoy et al., 2003;
Nierman et al., 2004).Bt is a soil saprophyte likeBp, but its natural
host is unknown. The sequence and mechanistic similarities
between BpBimA and BmBimA reflect their evolutionary lineage,
and it is interesting that the length and complexity of BmBimA
have decreased relative to those of BpBimA, mirroring changes
in the sizes of their respective genomes. The evolution of
BtBimA is less clear. We speculate that distinct BimA mecha-
nisms evolved in response to different host cell environments;
whereas BpBimA is optimized for infection of various mammals,
BmBimA is fine-tuned to function in equines, and BtBimA has
adapted to unknown hosts in the soil environment.
As a whole, our results highlight that even closely related spe-
cies have evolved tomimic adiverse spectrumof host actin-poly-
merizing pathways and that mimicry of different polymerization
mechanisms may influence key parameters of infection, such
as host cell fusion and bacterial dissemination. The acquisition
of distinct polymerization mechanisms may be relevant for the
evolution of virulence, as both highly virulent Burkholderia spe-
cies evolved mimics of host Ena/VASP proteins that nucleate,
elongate, and bundle actin filaments, as well as remove filament
capping proteins. However, the ramifications of these actin-reg-
ulatory capabilities on virulence remain to be appreciated. Study-
ing the divergent actin-based motility mechanisms of closely
related species represents a powerful approach to unravel the
evolution of pathogenic strategies for exploiting actin and to
reveal new principles that govern the generation, dynamics,
and regulation of distinct actin networks in cells.
EXPERIMENTAL PROCEDURES
Protein Purification and Fluorescent Labeling
SUMO-6XHis-BimA orthologs were expressed in E. coli and isolated by affin-
ity, anion-exchange, and/or gel-filtration chromatography. Alexa Fluor 488 C5
maleimide (Life Technologies) was used to label Cys-containing BpBimA and
BmBimA. Details of the purification and labeling methods are in the Extended
Experimental Procedures.
Bulk Actin Assembly Assays
Pyrene actin polymerization reactions contained rabbit skeletal muscle G-
actin (1 or 3 mM, 10% pyrene labeled) and BimA. Elongation assays were per-
formed by mixing F-actin with BimA and initiated by adding G-actin (250 nM).
For CP competition, 10 nMCPwasmixedwith F-actin seeds, BimAwas added
after 5min, and reactions were initializedwithG-actin (250 nM). For buffers and
further details, see Extended Experimental Procedures.
BimA Gel-Filtration Chromatography
BimA proteins were run over a Superdex 200 10/300 GL gel filtration column
(GE Healthcare) and detected by absorbance at 230 nm. See Extended Exper-
imental Procedures for further details.358 Cell 161, 348–360, April 9, 2015 ª2015 Elsevier Inc.Epifluorescence and TIRF Microscopy to Visualize Actin Filaments
For epifluorescence microscopy, polymerization reactions were stabilized
by adding 1 mM rhodamine-phalloidin (Life Technologies), and F-actin was
visualized as described previously (Haglund et al., 2010). TIRF microscopy
was performed as previously described (Kovar et al., 2006), except that reac-
tions contained 1 mM ATP-actin (33% rhodamine-labeled). At least 10 fila-
ments without BimA, or 20 filaments with 100 pM BpBimA or 10 nM BmBimA,
weremeasured over 240 s bymanually tracing filaments. See Extended Exper-
imental Procedures for further details.
G-Actin Binding Anisotropy
BimA proteins were added to 100 nM Alexa Fluor 488-labeled G-actin under
non-polymerizing conditions. Binding curves were fit using the Hill equation,
and the means of at least two titrations are reported. See Extended Experi-
mental Procedures for further details.
Bacterial Strain Construction
Parental Bt strain E264 was a gift from P. Cotter (University of North Carolina,
Chapel Hill, NC, USA). Bt bimA and Bt motA2 strains were gifts from C. French
and J. F.Miller (University of California, Los Angeles, CA, USA). Details of strain
construction are in the Extended Experimental Procedures and in Tables S1
and S2.
B. thailandensis Infection of Mammalian Cells
A549, COS7, HEK293T, and U2OS cells were from the University of California,
Berkeley tissue culture facility. Polyclonal cell lines stably expressing Lifeact-
EGFP (COS7) or F-Tractin-Wasabi (A549) were generated by lentiviral trans-
duction. For infections, bacteria grown in LB broth were added to pre-seeded
mammalian cells for 1 hr at 37C at high MOIs (100–200) before adding media
with gentamicin (Gm; 0.5 mg/ml). Fixed and live-cell analyses were performed
with samples at 8–15 hpi. For plaque assays, cells were infected (MOI of 0.1)
for 1 hr and overlaid with a mixture of agarose in media with Gm and imaged
by neutral red staining at 36 hpi. See Extended Experimental Procedures for
further details.
Image Analysis
Image analysis details are in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, two tables, and seven movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2015.02.044.
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